文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

用于治疗药物胞质递送的可生物降解纳米颗粒。

Biodegradable nanoparticles for cytosolic delivery of therapeutics.

作者信息

Vasir Jaspreet K, Labhasetwar Vinod

机构信息

Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.

出版信息

Adv Drug Deliv Rev. 2007 Aug 10;59(8):718-28. doi: 10.1016/j.addr.2007.06.003. Epub 2007 Jun 26.


DOI:10.1016/j.addr.2007.06.003
PMID:17683826
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2002520/
Abstract

Many therapeutics require efficient cytosolic delivery either because the receptors for those drugs are located in the cytosol or their site of action is an intracellular organelle that requires transport through the cytosolic compartment. To achieve efficient cytosolic delivery of therapeutics, different nanomaterials have been developed that consider the diverse physicochemical nature of therapeutics (macromolecule to small molecule; water soluble to water insoluble) and various membrane associated and intracellular barriers that these systems need to overcome to efficiently deliver and retain therapeutics in the cytoplasmic compartment. Our interest is in investigating PLGA and PLA-based nanoparticles for intracellular delivery of drugs and genes. The present review discusses the various aspects of our studies and emphasizes the need for understanding of the molecular mechanisms of intracellular trafficking of nanoparticles in order to develop an efficient cytosolic delivery system.

摘要

许多治疗药物都需要高效的胞质递送,这要么是因为这些药物的受体位于胞质溶胶中,要么是因为它们的作用位点是一个细胞内细胞器,需要通过胞质区室进行转运。为了实现治疗药物的高效胞质递送,人们开发了不同的纳米材料,这些材料考虑了治疗药物多样的物理化学性质(从大分子到小分子;从水溶性到水不溶性)以及这些系统为了在细胞质区室中有效递送和保留治疗药物而需要克服的各种与膜相关的和细胞内的障碍。我们感兴趣的是研究基于聚乳酸-羟基乙酸共聚物(PLGA)和聚乳酸(PLA)的纳米颗粒用于药物和基因的细胞内递送。本综述讨论了我们研究的各个方面,并强调了为开发高效的胞质递送系统而了解纳米颗粒细胞内运输分子机制的必要性。

相似文献

[1]
Biodegradable nanoparticles for cytosolic delivery of therapeutics.

Adv Drug Deliv Rev. 2007-8-10

[2]
Preparation of DHAQ-loaded mPEG-PLGA-mPEG nanoparticles and evaluation of drug release behaviors in vitro/in vivo.

J Mater Sci Mater Med. 2006-6

[3]
Biodegradable microparticles for sustained release of a new GnRH antagonist--part I: Screening commercial PLGA and formulation technologies.

Eur J Pharm Biopharm. 2003-11

[4]
Protein instability in poly(lactic-co-glycolic acid) microparticles.

Pharm Res. 2000-10

[5]
Sustained cytoplasmic delivery and anti-viral effect of PLGA nanoparticles carrying a nucleic acid-hydrolyzing monoclonal antibody.

Pharm Res. 2011-12-3

[6]
Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release.

Pharm Res. 1999-7

[7]
Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymer.

Biomaterials. 1997-9

[8]
Biodegradable nanoparticles for drug and gene delivery to cells and tissue.

Adv Drug Deliv Rev. 2003-2-24

[9]
Concepts and practices used to develop functional PLGA-based nanoparticulate systems.

Int J Nanomedicine. 2013-2-21

[10]
Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.

Int J Pharm. 2013-2-10

引用本文的文献

[1]
Aptamer-Coated PLGA Nanoparticles Selectively Internalize into Epithelial Ovarian Cancer Cells In Vitro and In Vivo.

Biomolecules. 2025-8-4

[2]
Squalene in Nanoparticles Improves Antiproliferative Effect on Human Colon Carcinoma Cells Through Apoptosis by Disturbances in Redox Balance.

Int J Mol Sci. 2024-12-4

[3]
Nanospheres as the delivery vehicle: novel application of ribosomal protein S2 in PLGA and chitosan nanospheres against acute toxoplasmosis.

Front Immunol. 2024

[4]
Revolutionizing Cancer Treatment: Harnessing the Power of Mesenchymal Stem Cells for Precise Targeted Therapy in the Tumor Microenvironment.

Curr Top Med Chem. 2025

[5]
From Polymeric Nanoformulations to Polyphenols-Strategies for Enhancing the Efficacy and Drug Delivery of Gentamicin.

Antibiotics (Basel). 2024-3-28

[6]
Development of high-efficiency superparamagnetic drug delivery system with MPI imaging capability.

Front Bioeng Biotechnol. 2024-3-20

[7]
Rejuvenating aged microglia by p16-siRNA-loaded nanoparticles increases amyloid-β clearance in animal models of Alzheimer's disease.

Mol Neurodegener. 2024-3-16

[8]
PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy.

Drug Deliv Transl Res. 2024-10

[9]
Membrane-Cloaked Nanoparticles for RNA Interference of β-Catenin in Triple-Negative Breast Cancer.

ACS Biomater Sci Eng. 2024-3-11

[10]
Mineralized Collagen/Polylactic Acid Composite Scaffolds for Load-Bearing Bone Regeneration in a Developmental Model.

Polymers (Basel). 2023-10-23

本文引用的文献

[1]
Abeta42 gene vaccination reduces brain amyloid plaque burden in transgenic mice.

J Neurol Sci. 2006-5-15

[2]
siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene.

J Control Release. 2006-5-15

[3]
Intracellular traffic and fate of protein transduction domains HIV-1 TAT peptide and octaarginine. Implications for their utilization as drug delivery vectors.

Bioconjug Chem. 2006

[4]
Targeting intracellular targets.

Curr Drug Deliv. 2004-7

[5]
Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI.

J Control Release. 2005-12-5

[6]
Intelligent polymers as nonviral vectors.

Gene Ther. 2005-10

[7]
Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention.

Mol Pharm. 2005

[8]
Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization.

J Cell Sci. 2005-8-1

[9]
Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells.

Mol Pharm. 2004

[10]
Cellular transfection to deliver alanine-glyoxylate aminotransferase to hepatocytes: a rational gene therapy for primary hyperoxaluria-1 (PH-1).

Am J Nephrol. 2005

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索